Myriad Genetics (MYGN) Non-Current Deffered Revenue (2015)
Myriad Genetics (MYGN) posted quarterly Non-Current Deffered Revenue of $10.4 million for Q1 2015.
Myriad Genetics (MYGN) Non-Current Deffered Revenue (2015) Analysis & Trends
Myriad Genetics has disclosed Non-Current Deffered Revenue across 1 years of filings, most recently posting $10.4 million for Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 17.00 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 10.45 Mn |